Changzhou STA, a new fully integrated R&D and cGMP manufacturing campus, covers 39 acres. The site design includes 10,000 m² R&D building, 9 pilot and commercial plants, an administration building, warehouses as well as various supporting units including utilities and waste treatment facilities. Changzhou site construction is being carried out in phases. The administration building, R&D building, the first large-scale manufacturing plant, supporting units and warehouses started operation at the beginning of 2016.
Upon completion, the site will employ more than 500 scientists and will add more than 1,000 m³ of reactor volume. Besides adding capacity, this state-of-the-art integrated campus will provide a unique one-site solution for STA customers to advance their active pharmaceutical ingredients (APIs) and advanced intermediates through preclinical and clinical development to global commercial launch.
Building on the foundations of STA business, we understand from personal experience what you need and expect from a service provider.Contact us